Welcome
The BCLC at the Hospital Clínic of Barcelona is a multidisciplinary team involving all relevant medical specialities devoted to clinical care, research and education in the field of liver cancer. It combines state of the art diagnosis and therapy, with the development of several research projects to evaluate new treatment options. These include laboratory studies in cell cultures or animal models and clinical trials in patients with liver cancer.


Short term fellowships
Recent Publications

JOURNAL ARTICLE
Clinical presentation, diagnosis and staging of cholangiocarcinoma
Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvisé M, Lamarca A

Liver International 2019;10.1111/liv.14086
Pubmed abstract
JOURNAL ARTICLE
Diagnosis of Hepatic Nodules in Patients at Risk for Hepatocellular Carcinoma: LI-RADS Probability Versus Certainty
Bruix J, Ayuso C Gastroenterology 2019;
Pubmed abstract
JOURNAL ARTICLE
Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma
Teufel M, Seidel H, Köchert K, Meinhardt G, Finn RS, Llovet JM, Bruix J

Gastroenterology 2019;10.1053/j.gastro.2019.01.261
Pubmed abstract
JOURNAL ARTICLE
Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib
Díaz-González Á, Sanduzzi-Zamparelli M, Sapena V, Torres F, LLarch N, Iserte G, Forner A, da Fonseca L, Ríos J, Bruix J, Reig M

Aliment Pharmacol Ther 2019;49:482-491
Pubmed abstract
JOURNAL ARTICLE
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: relevance of non-characterized nodules
Mariño Z, Darnell A, Lens S, Sapena V, Díaz A, Belmonte E, Perelló C, Calleja JL, Varela M, Rodriguez M, de Lope CR, Llerena S, Torras X, Gallego A, Sala M, Morillas RM, Minguez B, Llaneras J, Coll S, Carrion JA, Iñarrairaegui M, Sangro B, Vilana R, Sole M, Ayuso C, Ríos J, Forns X, Bruix J, Reig M

J Hepatology 2019;10.1016/j.jhep.2019.01.005
Pubmed abstract
JOURNAL ARTICLE
Carbon-ion radiotherapy for HCC-A potential tool to fulfil an unmet gap in the treatment algorithms?
Da Fonseca LG, Forner A. Liv Int 2018;38:2132-2133
Pubmed abstract
JOURNAL ARTICLE
Should Patients With NAFLD/NASH Be Surveyed for HCC?
Reig M, Gambato M, Man NK, Roberts JP, Victor D, Orci LA, Toso C. Transplantation 2019;103:39-44
Pubmed abstract